Literature DB >> 31738487

[SAFETY OF THE TREATMENT FOR VOLUNTARY PREGNANCY TERMINATION BY GESTATIONAL AGE. MEDELLÍN, COLOMBIA, 2013-2014].

Diana Patricia Restrepo-Bernal1, Alejandro Colonia-Toro2, Marle Isabel Duque-Giraldo3, Catalina Hoyos-Zuluaga4, Vanessa Cruz-Osorio5.   

Abstract

OBJECTIVE: To describe the safety of medical and surgical treatments used in women seeking voluntary pregnancy termination.
METHODS: Historical cohort of all pregnant women with up to 26 weeks of gestation who received treatment for voluntary pregnancy termination in a referral institution in Medellín, Colombia, between January 2013 and December 2014.Sampling was consecutive. Measured variables included sociodemographic and obstetric variables, undesired effects, and complications of the voluntary pregnancy termination treatment. A descriptive analysis was carried out.
RESULTS: Overall, 87 women were included. The mean age at the time of termination was 24 years (inter-quartile range [IQR] = 12), 69.0% were single, and 73,4% were unemployed. The main reason for termination was the risk to the mother's health in 61,0% of cases, followed by a history of sexual violence in 26.4% and fetal malformations in 12.6%; a total of 70 women (80,4%) had less than 18 weeks of gestation and were treated with misoprostol plus manual vacuum aspiration; 17 (19,6%) had between 18 and 26 weeks of gestation and were treated with misoprostol followed by dilation and curettage. The first group (gestational age <18 weeks) experienced undesired effects such as pain and vomiting; in the second group (> or equal to 18 weeks), 41.0% of the women experienced hemorrhage.
CONCLUSIONS: The risk to the mother's health was the main reason for the termination of pregnancy. Termination before 18 weeks was found to be safe, while termination between 18 and 26 weeks using misoprostol and curettage was associated with a high frequency of hemorrhage. Copyright
© 2019 This is an open-access article distributed under the terms of the Creative Commons Attribution License by-nc-nd/4.0.

Entities:  

Keywords:  salud mental; Therapeutic abortion ; aborto terapéutico; abuso sexual; anomalías congénitas ; congenital abnormalities; embarazo de alto riesgo; high risk pregnancy; mental health; sexual abuse

Mesh:

Substances:

Year:  2019        PMID: 31738487     DOI: 10.18597/rcog.3267

Source DB:  PubMed          Journal:  Rev Colomb Obstet Ginecol        ISSN: 0034-7434


  1 in total

1.  Safety of voluntary interruption of pregnancy (VIP) in two healthcare institutions in Medellín, Colombia, in 2019. Historical cohort

Authors:  Edgar Fernando Cárdenas-Arias; Diana Elizabeth Escudero-Cardona; Edgar Adel Noreña-Mosquera
Journal:  Rev Colomb Obstet Ginecol       Date:  2022-03-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.